TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 102 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $263,000 | +29.6% | 3,475 | +46.3% | 0.00% | +50.0% |
| Q2 2019 | $203,000 | -5.1% | 2,375 | +20.3% | 0.00% | 0.0% |
| Q1 2019 | $214,000 | +151.8% | 1,975 | +97.5% | 0.00% | +100.0% |
| Q4 2018 | $85,000 | -13.3% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $98,000 | -15.5% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $116,000 | -55.2% | 1,000 | -56.5% | 0.00% | -50.0% |
| Q3 2017 | $259,000 | +44.7% | 2,300 | +43.8% | 0.00% | 0.0% |
| Q2 2017 | $179,000 | -4.3% | 1,600 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $187,000 | +11.3% | 1,600 | 0.0% | 0.00% | +100.0% |
| Q4 2016 | $168,000 | +281.8% | 1,600 | +300.0% | 0.00% | – |
| Q3 2016 | $44,000 | -81.1% | 400 | -75.0% | 0.00% | -100.0% |
| Q2 2016 | $233,000 | +28.0% | 1,600 | +35.9% | 0.00% | 0.0% |
| Q4 2015 | $182,000 | – | 1,177 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL MANAGEMENT LP | 1,104,168 | $154,849,000 | 80.27% |
| Consonance Capital Management LP | 378,372 | $53,063,000 | 7.89% |
| Moab Capital Partners | 93,133 | $13,061,000 | 6.27% |
| Greywolf Capital Management LP | 277,936 | $38,978,000 | 5.77% |
| Perceptive Advisors | 301,333 | $42,260,000 | 4.15% |
| Valentine Capital Asset Management, Inc. | 141,270 | $19,812,000 | 3.81% |
| Raging Capital Management, LLC | 253,236 | $35,514,000 | 3.78% |
| Ativo Capital Management LLC | 18,058 | $2,532,000 | 1.10% |
| Geduld E E | 8,000 | $1,122,000 | 0.70% |
| Assured Investment Management LLC | 192,389 | $26,981,000 | 0.46% |